slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5.240 KRW | +0,77% | +2,34% | -15,48% |
2023 | PharmGen Science, Inc. meldt winstresultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Vakgebied
Aantal werknemers: 250
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 150 931 | 100,0 % | 166 779 | 100,0 % | +10,50% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
99,5
%
| 150 065 | 99,4 % | 165 885 | 99,5 % | +10,54% |
Overseas
0,5
%
| 866 | 0,6 % | 894 | 0,5 % | +3,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hee-Deok Park
CEO | Chief Executive Officer | 56 | 27-03-19 |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Seung-Yeol Lee
BRD | Director/Board Member | 44 | - |
Seo-In Kim
AUD | Comptroller/Controller/Auditor | 42 | 26-03-20 |
Hae-Doo Lee
PRN | Corporate Officer/Principal | 61 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Seung-Yeol Lee
BRD | Director/Board Member | 44 | - |
Hye-Yeon Kim
CEO | Chief Executive Officer | 67 | - |
Nam-Hyun Ryu
BRD | Director/Board Member | 58 | - |
Hee-Deok Park
CEO | Chief Executive Officer | 56 | 27-03-19 |
Dong-Hwa Yoon
BRD | Director/Board Member | 63 | - |
In-Ki Lee
BRD | Director/Board Member | 61 | 26-03-20 |
Kwang-Hae Lee
BRD | Director/Board Member | 52 | 26-03-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 18 178 525 | 15 763 523 ( 86,72 %) | 41 910 ( 0,2305 %) | 86,72 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ACCESS BIO, INC. 25.22% | 9 171 729 | 25.22% | 50 823 485 $ |
PHARMGEN SCIENCE, INC. 0.23% | 41 910 | 0.23% | 175 579 $ |
Bedrijfsgegevens
PharmGen Science, Inc.
50 Pharmaceutical Ind. Complex 2-gil Hyangnam-myeon
18622, Hwaseong
+
http://www.pharmgenscience.comSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-15,48% | 69,05 mln. | |
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
+37,46% | 11,43 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. |
- Beurs
- Aandelen
- Koers A004720
- Onderneming PharmGen Science, Inc.